miR-32 promotes MYC-driven prostate cancer.
Scaravilli M, Koivukoski S, Gillen A, Bouazza A, Ruusuvuori P, Visakorpi T, Latonen L.
Scaravilli M, et al. Among authors: bouazza a.
Oncogenesis. 2022 Mar 1;11(1):11. doi: 10.1038/s41389-022-00385-8.
Oncogenesis. 2022.
PMID: 35228520
Free PMC article.